663921-15-1 | 3-Amino(peg4)propionic acid

Packsize	Purity	Availability	Price	Discounted Price
250mg	97%	in stock	$45.00	$32.00
1g	≥95%	in stock	$49.00	$34.00
25g	95%	in stock	$829.00	$580.00

Description

• Catalog Number: AB48714
• Chemical Name: 3-Amino(peg4)propionic acid
• CAS Number: 663921-15-1
• Molecular Formula: C11H23NO6
• Molecular Weight: 265.3034
• MDL Number: MFCD11041129
• SMILES: NCCOCCOCCOCCOCCC(=O)O

Computed Properties

• Complexity: 190
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 18
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 14
• XLogP3: -4.1

Literature

• 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression.

  Molecular imaging 20111001

• Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.

  Bioconjugate chemistry 20110817

• Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

  Theranostics 20110101

• Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.

  Theranostics 20110101

• Antibody-maytansinoid conjugates designed to bypass multidrug resistance.

  Cancer research 20100315

• Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.

  Molecular imaging 20100201

• 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.

  Bioconjugate chemistry 20090819

• Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.

  European journal of nuclear medicine and molecular imaging 20090801

• (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.

  European journal of nuclear medicine and molecular imaging 20090601

• Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.

  Bioconjugate chemistry 20090401

• Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.

  Molecular pharmaceutics 20090101

• DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.

  European journal of nuclear medicine and molecular imaging 20070801

• Influence of different spacers on the biological profile of a DOTA-somatostatin analogue.

  Bioconjugate chemistry 20070101

• Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer.

  Bioconjugate chemistry 20060101